If new research shifts the benefit-harm balance of a USPSTF recommendation, clinicians should do what?

• A. Only discuss it verbally without documentation.
• B. Ignore it until official changes are published.
• C. Stop performing the service entirely.
• D. Re-evaluate and potentially adjust the care plan in light of updated guidance.

Answer: (D)

When new research shifts the balance of benefits and harms for a USPSTF recommendation, clinicians should re-evaluate the patient’s risk and adjust the care plan in light of the updated evidence and guidance. This keeps care aligned with the most current knowledge and supports shared decision-making with the patient. Documentation should capture the updated rationale and the revised plan. The other options don’t fit because they neglect updating practice based on new evidence (either by not documenting and updating care, delaying action until official changes, or stopping the service altogether), which could deprive the patient of beneficial care or expose them to unnecessary risks.